Global Biliary Tract Cancer Market (2024 Edition): Analysis By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer), By Therapeutics, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Biliary Tract Cancer Market (2024 Edition): Analysis By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer), By Therapeutics, By Region, By Country: Market Insights and Forecast (2020-2030)


Executive Summary

Azoth Analytics has released a research report titled “Global Biliary Tract Cancer Market (2024 Edition)” which provides an analysis of the Global Biliary Tract Cancer industry in terms of market segmentation By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer), By Therapeutics (Gemcitabine + Cisplatin, Gemcitabine + Cisplatin + Other targeted therapies, Gemcitabine, Other targeted therapies, and Gemcitabine + Other chemotherapy combinations) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Biliary Tract Cancer Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Biliary Tract Cancer market showcased growth at a CAGR of 9.53% during 2020-2023. The market was valued at USD 696.75 Million in 2023 which is expected to reach USD 1424.09 Million in 2030.

Biliary tract cancer is a relatively uncommon malignancy, accounting for approximately 3% of all gastrointestinal cancers worldwide. This translates to a significant number of cases when considering the global population. Countries in Southeast Asia, particularly those with high rates of parasitic infections like Clonorchis sinensis and Opisthorchis viverrini, have significantly higher rates of biliary tract cancer. These infections cause chronic inflammation of the bile ducts, which can increase the risk of cancer development. Other factors contributing to the higher incidence in this region include environmental pollutants, dietary habits, and genetic susceptibility.

This market has been witnessing gradual growth due to rising incidence rates, advancements in diagnostic technologies, and the development of targeted therapies. However, challenges persist due to the rarity of the disease, which limits the availability of large-scale clinical data and complicates drug development efforts.

The limited availability of effective treatments for biliary tract cancer, coupled with the low survival rates associated with the disease, has created a significant and urgent need for the development of innovative therapeutic approaches.

Scope of the Report:
  • The report analyses the Biliary Tract Cancer Market by Value (USD Million).
  • The report analyses the Biliary Tract Cancer Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
  • The report presents the analysis of Biliary Tract Cancer Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Biliary Tract Cancer Market By Indication (Extrahepatic Bile Duct Cancer, Intrahepatic Bile Duct Cancer)
  • The report analyses the Biliary Tract Cancer Market By Therapeutics (Gemcitabine + Cisplatin, Gemcitabine + Cisplatin + Other targeted therapies, Gemcitabine, Other targeted therapies, and Gemcitabine + Other chemotherapy combinations).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Indication, and By Therapeutics.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Johnson & Johnson, Sanofi, Novartis, Pfizer, Bayer AG, Merck & Co., Inc., Teva Pharmaceuticals, Eli Lily & Co, Bristol Myers Squibb, and F. Hoffmann-La Roche AG.


1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
2.1 Develop Comprehensive Care Protocols
2.2 Improve Access to Treatments
3. Global Biliary Tract Cancer Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Biliary Tract Cancer Market
3.2 Global Prevalence of Gallbladder and biliary tract cancer, 2021
3.3 Global Incidence of Gallbladder and biliary tract cancer, 2021
3.4 Total Incident Cases of Biliary tract cancers in the 7 Major Markets 2020-2024
3.5 Global Biliary Tract Cancer Market: Dashboard
3.6 Global Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
3.7 Global Biliary Tract Cancer Market: Market Value Assessment
3.8 Assessment Degree of Impact of COVID-19 on Biliary Tract Cancer Market
3.9 Global Biliary Tract Cancer Market Segmentation: By Indication
3.9.1 Global Biliary Tract Cancer Market, By Indication Overview
3.9.2 Global Biliary Tract Cancer Market Attractiveness Index, By Indication
3.9.3 Global Biliary Tract Cancer Market Size, By Extrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Biliary Tract Cancer Market Size, By Intrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
3.10 Global Biliary Tract Cancer Market Segmentation: By Therapeutics
3.10.1 Global Biliary Tract Cancer Market, By Therapeutics Overview
3.10.2 Global Biliary Tract Cancer Market Attractiveness Index, By Therapeutics
3.10.3 Global Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin, By Value, 2020H-2030F (USD Million & CAGR)
3.10.4 Global Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin + Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
3.10.5 Global Biliary Tract Cancer Market Size, By Gemcitabine, By Value, 2020H-2030F (USD Million & CAGR)
3.10.6 Global Biliary Tract Cancer Market Size, By Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
3.10.7 Global Biliary Tract Cancer Market Size, By Gemcitabine + Other chemotherapy combinations, By Value, 2020H-2030F (USD Million & CAGR)
4. Biliary Tract Cancer Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Biliary Tract Cancer Market: Historic and Forecast
5.1 Americas Biliary Tract Cancer Market: Snapshot
5.2 Americas Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.3 Americas Biliary Tract Cancer Market: Key Factors
5.4 Americas Biliary Tract Cancer Market: Segment Analysis
5.5 Americas Biliary Tract Cancer Market Segmentation: By Indication
5.5.1 Americas Biliary Tract Cancer Market, By Indication Overview
5.5.2 Americas Biliary Tract Cancer Market Size, By Extrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Biliary Tract Cancer Market Size, By Intrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Biliary Tract Cancer Market Segmentation: By Therapeutics
5.6.1 Americas Biliary Tract Cancer Market, By Therapeutics Overview
5.6.2 Americas Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin + Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
5.6.4 Americas Biliary Tract Cancer Market Size, By Gemcitabine, By Value, 2020H-2030F (USD Million & CAGR)
5.6.5 Americas Biliary Tract Cancer Market Size, By Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
5.6.6 Americas Biliary Tract Cancer Market Size, By Gemcitabine + Other chemotherapy combinations, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Biliary Tract Cancer Market Segmentation: By Country
5.7.1 Americas Biliary Tract Cancer Market, by Country Overview
5.7.2 United States Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.2.1 United States Biliary Tract Cancer Market, By Indication
5.7.2.2 United States Biliary Tract Cancer Market, By Therapeutics
5.7.3 Canada Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.3.1 Canada Biliary Tract Cancer Market, By Indication
5.7.3.2 Canada Biliary Tract Cancer Market, By Therapeutics
5.7.4 Rest of Americas Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.7.4.1 Rest of Americas Biliary Tract Cancer Market, By Indication
5.7.4.2 Rest of Americas Biliary Tract Cancer Market, By Therapeutics
6. Europe Biliary Tract Cancer Market: Historic and Forecast
6.1 Europe Biliary Tract Cancer Market: Snapshot
6.2 Europe Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.3 Europe Biliary Tract Cancer Market: Key Factors
6.4 Europe Biliary Tract Cancer Market: Segment Analysis
6.5 Europe Biliary Tract Cancer Market Segmentation: By Indication
6.5.1 Europe Biliary Tract Cancer Market, By Indication Overview
6.5.2 Europe Biliary Tract Cancer Market Size, By Extrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Biliary Tract Cancer Market Size, By Intrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Biliary Tract Cancer Market Segmentation: By Therapeutics
6.6.1 Europe Biliary Tract Cancer Market, By Therapeutics Overview
6.6.2 Europe Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin + Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
6.6.4 Europe Biliary Tract Cancer Market Size, By Gemcitabine, By Value, 2020H-2030F (USD Million & CAGR)
6.6.5 Europe Biliary Tract Cancer Market Size, By Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
6.6.6 Europe Biliary Tract Cancer Market Size, By Gemcitabine + Other chemotherapy combinations, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Biliary Tract Cancer Market Segmentation: By Country
6.7.1 Europe Biliary Tract Cancer Market, by Country Overview
6.7.2 Germany Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.2.1 Germany Biliary Tract Cancer Market, By Indication
6.7.2.2 Germany Biliary Tract Cancer Market, By Therapeutics
6.7.3 United Kingdom Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.3.1 United Kingdom Biliary Tract Cancer Market, By Indication
6.7.3.2 United Kingdom Biliary Tract Cancer Market, By Therapeutics
6.7.4 France Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.4.1 France Biliary Tract Cancer Market, By Indication
6.7.4.2 France Biliary Tract Cancer Market, By Therapeutics
6.7.5 Italy Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.5.1 Italy Biliary Tract Cancer Market, By Indication
6.7.5.2 Italy Biliary Tract Cancer Market, By Therapeutics
6.7.6 Spain Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.6.1 Spain Biliary Tract Cancer Market, By Indication
6.7.6.2 Spain Biliary Tract Cancer Market, By Therapeutics
6.7.7 Rest of Europe Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.7.7.1 Rest of Europe Biliary Tract Cancer Market, By Indication
6.7.7.2 Rest of Europe Biliary Tract Cancer Market, By Therapeutics
7. Asia Pacific Biliary Tract Cancer Market: Historic and Forecast
7.1 Asia Pacific Biliary Tract Cancer Market: Snapshot
7.2 Asia Pacific Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Biliary Tract Cancer Market: Key Factors
7.4 Asia Pacific Biliary Tract Cancer Market: Segment Analysis
7.5 Asia Pacific Biliary Tract Cancer Market Segmentation: By Indication
7.5.1 Asia Pacific Biliary Tract Cancer Market, By Indication Overview
7.5.2 Asia Pacific Biliary Tract Cancer Market Size, By Extrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Biliary Tract Cancer Market Size, By Intrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Biliary Tract Cancer Market Segmentation: By Therapeutics
7.6.1 Asia Pacific Biliary Tract Cancer Market, By Therapeutics Overview
7.6.2 Asia Pacific Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin + Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
7.6.4 Asia Pacific Biliary Tract Cancer Market Size, By Gemcitabine, By Value, 2020H-2030F (USD Million & CAGR)
7.6.5 Asia Pacific Biliary Tract Cancer Market Size, By Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
7.6.6 Asia Pacific Biliary Tract Cancer Market Size, By Gemcitabine + Other chemotherapy combinations, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Biliary Tract Cancer Market Segmentation: By Country
7.7.1 Asia Pacific Biliary Tract Cancer Market, by Country Overview
7.7.2 China Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.2.1 China Biliary Tract Cancer Market, By Indication
7.7.2.2 China Biliary Tract Cancer Market, By Therapeutics
7.7.3 Japan Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.3.1 Japan Biliary Tract Cancer Market, By Indication
7.7.3.2 Japan Biliary Tract Cancer Market, By Therapeutics
7.7.4 India Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.4.1 India Biliary Tract Cancer Market, By Indication
7.7.4.2 India Biliary Tract Cancer Market, By Therapeutics
7.7.5 Rest of Asia Pacific Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.7.5.1 Rest of Asia Pacific Biliary Tract Cancer Market, By Indication
7.7.5.2 Rest of Asia Pacific Biliary Tract Cancer Market, By Therapeutics
8. Middle East and Africa Biliary Tract Cancer Market: Historic and Forecast
8.1 Middle East and Africa Biliary Tract Cancer Market: Snapshot
8.2 Middle East and Africa Biliary Tract Cancer Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.3 Middle East and Africa Biliary Tract Cancer Market: Key Factors
8.4 Middle East and Africa Biliary Tract Cancer Market: Segment Analysis
8.5 Middle East and Africa Biliary Tract Cancer Market Segmentation: By Indication
8.5.1 Middle East and Africa Biliary Tract Cancer Market, By Indication Overview
8.5.2 Middle East and Africa Biliary Tract Cancer Market Size, By Extrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East and Africa Biliary Tract Cancer Market Size, By Intrahepatic Bile Duct Cancer, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East and Africa Biliary Tract Cancer Market Segmentation: By Therapeutics
8.6.1 Middle East and Africa Biliary Tract Cancer Market, By Therapeutics Overview
8.6.2 Middle East and Africa Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East and Africa Biliary Tract Cancer Market Size, By Gemcitabine + Cisplatin + Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
8.6.4 Middle East and Africa Biliary Tract Cancer Market Size, By Gemcitabine, By Value, 2020H-2030F (USD Million & CAGR)
8.6.5 Middle East and Africa Biliary Tract Cancer Market Size, By Other targeted therapies, By Value, 2020H-2030F (USD Million & CAGR)
8.6.6 Middle East and Africa Biliary Tract Cancer Market Size, By Gemcitabine + Other chemotherapy combinations, By Value, 2020H-2030F (USD Million & CAGR)
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Biliary Tract Cancer Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Industry Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Biliary Tract Cancer Market
11.4 Company Profiles
11.4.1 Johnson & Johnson
11.4.2 Sanofi
11.4.3 Novartis
11.4.4 Pfizer
11.4.5 Bayer AG
11.4.6 Merck & Co., Inc.
11.4.7 Teva Pharmaceuticals
11.4.8 Eli Lily & Co.
11.4.9 Bristol Myers Squibb
11.4.10 F. Hoffmann-La Roche AG
12. About Us & Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings